Pharmacological Modulation and Integrative Therapeutic Strategies in the Management of Type 2 Diabetes Mellitus: A Comprehensive Review

Abstract

Background: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, impaired insulin secretion, and persistent hyperglycemia. It affects over 500 million adults globally and accounts for a major share of non-communicable disease–related morbidity, mortality, and healthcare costs. The rising prevalence is driven by sedentary lifestyles, unhealthy diets, and genetic predisposition. Aim: This paper aims to elucidate the pathophysiological mechanisms of T2DM and review recent therapeutic advances, including both conventional and integrative management approaches. Methods: A narrative review of recent literature was conducted to summarize data on pharmacological innovations, lifestyle interventions, and complementary therapies with clinically relevant outcomes in glycemic control. Results: Conventional drugs such as metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, and insulin remain the backbone of therapy; however, adverse effects and poor adherence limit their long-term efficacy. Recent therapeutic innovations—such as SGLT2 inhibitors and GLP-1 receptor agonists—have demonstrated not only improved glycemic control but also cardiovascular and renal benefits in clinical trials. Moreover, herbal adjuvants with anti-hyperglycemic and antioxidant properties (e.g., Momordica charantia, Gymnema sylvestre, Cinnamomum verum) are gaining scientific attention as complementary strategies. Conclusion: A comprehensive understanding of both conventional and integrative modalities is essential to developing a more patient-centered, sustainable, and effective approach to diabetes care.